Biotech Pulse: Tau Drugs, SSRI Tapers, and a Sanofi Wearable Win
A Readout newsletter recap notes buzz around daraxonrasib and tau therapies at major meetings, U.S. HHS is drafting guidance on tapering SSRIs, and the FDA cleared Sanofi’s wearable injector for a myeloma drug.